News
Hailing from South Korea, Letybo is the sixth and most recent neuromodulator approved by the FDA. Here, dermatologists unpack ...
8h
Pharmaceutical Technology on MSNADHD drugs back in the spotlight after study debunks rising prevalenceA study found no rise in ADHD cases, though some drugs for the disorder are still in shortage amid high demand.
2d
The Takeout on MSNMountain Dew And Doritos Might Receive A Disturbing Warning Label In This State (And It's Not California)Snack packaging's headed for a makeover in this state. If warnings take the fun out of possibly ingesting banned ingredients ...
Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after ...
Abeona's ZEVASKYN approval and a $3.1 million price point are undervalued by the market. Find out why ABEO stock is a Buy.
The study, led by the U.S. Centers for Disease Control and Prevention (CDC), found that people who took bismuth subsalicylate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results